Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Salbutamol vs Epinephrine for Transient Tachypnea of the Newborn
IRCT20221028056324N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in transient tachypnea of the newborn (TTN) comparing Nebulized salbutamol with Nebulized epinephrine (2 arms). Started Oct 2023; status: completed.
02
Drugs
salbutamolepinephrine
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on IRCT20221028056324N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221028056324N1.